Dear Dr. Wang: 

On behalf of the Peking University Health Science Center (PKUHSC) and Juntendo University (JUNTENDO) Joint Institute for Medical Research (JI), we are pleased to inform you that your grant application titled, “Development and validation of a novel combined cell therapy using injectable arterialvascular organoids (AVOs) and RE-01 cells for treating ischemic diseases.” has been approved for funding in the amount of 1,000,000 CNY (500,000 CNY from PKUHSC and 500,000 CNY from Juntendo).